AstraZeneca
AstraZeneca plc (/ˌæstrəˈzɛnəkə/) is a British–Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, England.[1] It is registered in London, United Kingdom. AstraZeneca Plc was formed in 1999 by merging the Swedish Astra AB and the British Zeneca Ltd. Drugs produced by the company are sold in more than 100 countries. More than 57 thousand people work for the company. AstraZeneca's factories are in 20 countries. Sales in 2012 amounted to almost 28 billion dollars.
Pascal Soriot was the best-paid FTSE chief executive in 2022, with a total package of £15.3 million.
The share price has risen about 80% in the past five years.[2]
AstraZeneca creates treatments for cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.[3]
AstraZeneca Media
Oxford–AstraZeneca COVID-19 vaccine
The AstraZeneca R&D facility in Gothenburg, Sweden
The new AstraZeneca Corporate HQ under construction in Cambridge, England
Seat of the European Commission, which negotiated a contract with AstraZeneca
_I_(cropped).jpg)
References
- ↑ "Registered office and corporate headquarters". AstraZeneca. Retrieved 27 February 2020.
- ↑ Pickard, Jim; Parker, George; O’Dwyer, Michael (2023-08-21). "FTSE 100 bosses given average 16% pay rises". Financial Times. https://www.ft.com/content/3a55f34e-466b-4649-8f75-95188fe7ce80. Retrieved 2023-08-22.
- ↑ "AstraZeneca - About Us". astrazeneca.com.
.svg){kind=small}
This short article about the United Kingdom can be made longer. You can help Wikipedia by adding to it.